<?xml version="1.0" encoding="UTF-8"?>
<p id="p0065">Although wastewater surveillance of SARS-CoV-2 provides a powerful tool to evaluate disease incidence at the community level, it is clear that they also need to be integrated into other public health initiatives [e.g. campaign-based and randomised testing of individuals (i.e. presence of pathogen or antibodies), clinical case reporting, and mobile-based contact-tracking and self-reporting systems [
 <xref rid="bib44" ref-type="bibr">44</xref>]. This represents a significant challenge considering the poor integration of the environmental and clinical science communities. It may also require a harmonization of approaches (e.g. viral sequencing platforms and databases to match SARS-CoV-2 lineages detected in clinical and wastewater samples). It is also important to consider how best to ethically and legally balance public health with civil liberties when handling this information [
 <xref rid="bib45" ref-type="bibr">45</xref>]. One of the benefits of wastewater, however, is that it has limited sociological bias with few if any ethical issues.
</p>
